glutathione and alzheimer's disease New biomarkers for diagnosing Impaired Glutathione Synthesis in Neurodegeneration
Description
Risperidone or its metabolite plasma levels did not show the difference in responders and nonresponders, or when comparing patients with or without ADRs
Traditional diagnostic approaches often depend on clinicians' subjective judgment, which may lead to misdiagnosis or missed cases
2004;50(Suppl):P175
But if the drug forms an inclusion complex with a cyclodextrin, its release is controlled which reduces the risk of severe side effects [46]
Whether for skin health, energy, or detoxification, this treatment provides a natural and effective way to support overall well-being
